9 results match your criteria: "USL Toscana Centro-Prato Hospital[Affiliation]"

Sarcoidosis-Like Reaction in Melanoma Patients Receiving Immunotherapy or Targeted Therapy.

Case Rep Oncol Med

December 2024

Oncology Unit Fondazione, IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

This case series highlights the complexity of sarcoidosis-like reactions (SLRs) during cancer treatment, specifically in patients receiving immunotherapy or targeted therapies for melanoma. SLRs can either mimic disease progression or present as part of the clinical manifestation, making diagnosis and treatment challenging. Our study reviewed the medical records of 31 patients who were candidates for postoperative treatment between June 2022 and June 2024.

View Article and Find Full Text PDF

Psoriasis is a chronic immune-mediated disease that is linked to an increased risk of cancer. Although numerous studies have explored whether neoplasms are concurrent conditions or are induced by psoriasis, a definitive definition remains elusive. In this study, we conducted a comprehensive narrative literature review to offer practical guidance to oncologists and dermatologists regarding the initiation and discontinuation of biologics for psoriasis.

View Article and Find Full Text PDF

The use of multiple drugs acting as modulators of the immune system are common among patients with severe autoimmune diseases. In these clinical scenarios, great attention should be placed on diagnosing infective cutaneous disorders that can underly iatrogenic immunosuppression. Here within, we report a rare case of molluscum contagiosum eruption on the face and the scalp during an immunomodulating treatment for rheumatoid arthritis, with clinical and dermatoscopic characterization.

View Article and Find Full Text PDF

In Situ Melanoma of the Nipple and Areola: A Dermoscopic Report in Two New Cases.

Dermatol Pract Concept

March 2021

Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, Policlinico Sant'Orsola-Malpighi, University of Bologna, Italy.

View Article and Find Full Text PDF

Vulvar melanoma: How good are we in the follow-up of high-risk women?

Dermatol Ther

November 2020

Unit of Dermatology, Department of Experimental Diagnostic and Specialty Medicine, Policlinico Sant' Orsola-Malpighi, University of Bologna, Bologna, Italy.

View Article and Find Full Text PDF

Hidradenoma papilliferum (HP) is a rare, slow-growing, benign adnexal tumour with apocrine differentiation. It usually affects the anogenital region in adult women and is clinically polymorphous, mimicking other benign or malignant neoformations. The dermoscopic features of vulval HP have not been reported yet.

View Article and Find Full Text PDF

Thin vulvar melanoma: a challenging diagnosis. Dermoscopic features of a case series.

Clin Exp Dermatol

March 2020

Melanoma Division, IRCCS Istituto Europeo di Oncologia, Milan, Italy.

Background: Vulvar melanoma (VM) is rare and is often diagnosed late. Dermoscopy may aid in its recognition, differentiating VM from other more common vulvar lesions, such as melanosis and naevi. However, little is known about the dermoscopic features of thin VM.

View Article and Find Full Text PDF

The last decades were characterized by a worldwide increasing incidence in melanoma. Almost 35% of diagnosed with melanoma women are in childbearing age. Malignant melanoma is the most common malignancy during pregnancy.

View Article and Find Full Text PDF